pendent upon the immune status of the host, and that X-rays and anti-tumour immunity do not act synergistically in tumour-cell killing.
The tumour used was the ascites sarcoma BP8, and experiments were performed between weekly Passages 268 and 315 of the tumour in inbred 10-12-weekold DMC/Ps mice. Anti-tumour immunity was assessed by a terminal dilution method (Hewitt & Wilson, 1959) to give TD50 (the number of viable tumour cells required to trasmit the tumour and give Accepted 15 January 1979 rise to lethal growth in 50% of the animals). SD50 (Maruyama, 1967) , the radiation dose to a challenge of tumour cells required to prevent tumour takes in half of recipients, was estimated using mice carrying measured amounts of antitumour immunity.
It has previously been demonstrated that reproducible immunity against viable BP8 cell challenge can be obtained in mice after i.p. inoculation of lethally irradiated (LI) BP8 cells . In the present experiments, cells were taken from exponentially growing tumours and counted in a haemacytometer using phase-contrast microscopy. Cells for immunization were prepared by exposing a suspension of 108 cells/ml in Eagle's minimum essential medium with 2u/ml heparin (HMEM) 101/2 (i.e. 3-16) to cover the range 0-100% survival. TD50 was estimated using probit transformation (Finney, 1962) challenge and the logarithm of the viablecell challenge dose. These coordinates were fitted to a linear relationship using weighted mean squares, the weights being given by maximum-likelihood techniques (Finney, 1964) . The heterogeneity of the relationship was checked by the chisquared test and, as this was more than 80% in all cases, the standard error in this estimator was calculated as suggested by Finney rad and extrapolation number, n 4 7 The radiosensitivity of BP8 cells, expressed as Do, is similar to the value of 95 rad found when the cells were tested in vitro [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] mice which were given selected immunizing doses of LI cells and used 14 days later in subgroups of 5-6 as recipients for either TD50 or SD50 estimations. TD50s were quantitated as already described with the addition of appropriate numbers of LI cells to give uniform inocula of 2 x105.
Cells for SD50 were obtained by irradiating a suspension of cells at a concentration of 107/ml in vitro with increasing doses of X-rays at 100 rad/min in an atmosphere of 95% air: 5 % C02. After each irradiation 0.5 ml of cells was removed and dilutions were made to give the challenge dose of 2x 105 cells in 0*5 ml. X-ray doses were chosen to give a range of survival of 0-100% in groups of recipients. SD50 was estimated using probit transformation to linearize the relationship between percent survivors of 90 days and the dose of X-rays given to the challenge dose of cells. (Fig. 2) . Thus it is implied that the destruction of viable BP8 cells by immunity is independent of the process of their depletion by X-rays.
In these experiments we have demonstrated that, provided the number of viable cells remaining after the proportional cell killing by X-rays is smaller than the number against which the recipient mouse is shown to be immune, the animal survives. Also, since the total cell killing is not greater than the sum of that attributable to the two agencies taken separately, there is no synergistic interaction. This work was supported by Grant CA 14117 awarded by the National Cancer Institute, DHEW.
